Menu
GWAS Study

Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes.

Murea M, Lu L, Ma L et al.

21546767 PubMed ID
GWAS Study Type
610 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MM
Murea M
LL
Lu L
ML
Ma L
HP
Hicks PJ
DJ
Divers J
MC
McDonough CW
LC
Langefeld CD
BD
Bowden DW
FB
Freedman BI
Chapter II

Abstract

Summary of the research findings

African-Americans (AAs) with diabetes have high incidence rates of end-stage renal disease (ESRD) with associated high mortality. Genetic factors modulating the risk of mortality on dialysis are poorly understood.

610 African American type 2 diabetes cases

Chapter III

Study Statistics

Key metrics and study information

610
Total Participants
GWAS
Study Type
No
Replicated
African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.